Key result
Simvastatin reduces chronic inflammation and promotes parotid gland remodeling in hyperlipidemic rats.
Why the study?
The role of hyperlipidemia in the microstructure of the parotid gland and the potential amelioration by statin treatment were investigated.
Does simvastatin ameliorate morphological changes of the parotid gland induced by experimental hyperlipidemia in Wistar rats?
Does simvastatin ameliorate morphological changes of the parotid gland induced by experimental hyperlipidemia in Wistar rats?
Simvastatin may ameliorate parotid gland morphological changes and inflammation induced by hyperlipidemia in a rat model.
Answers are grounded in this paper and cite their sources.
May inform statin effects on salivary glands in hyperlipidemia; leaves open human translation and clinical relevance.
Objective. The aim of this study was to investigate the role of hyperlipidemia in the microstructure of parotid gland and its possible amelioration through statin treatment on Wistar rats. Methods. Forty Wistar rats (111.06 ± 3.36 g) were divided into 4 groups (A1, A2 controls, B1, B2 experimental). Groups A1 and A2 consumed normal cereal rodents diet during the experimental hyperlipidemic mixture. The A2 and B2 were treated with simvastatin (Zocor) 40 mg/kg/daily p.o. for 3 months. Results. Total cholesterol, triglycerides, high density lipoproteins, and low density lipoproteins were increased in groups B1 and B2 while the parotid weight was decreased. The histological findings demonstrated changes in the parotid gland morphology of the B1 and B2, such as the presence of chronic inflammation, fibrosis, lipocytes, and foci of lymphocytic infiltration. Conclusions. The influence of statin tended to predominate over the chronic inflammation while the lipocytes were decreased and remodelling of the parotid's structure occurred.
No takes yet. Share an insight, caveat, or question.
Daskala et al. (2011) studied Experimental Hyperlipidemia (n=40). Simvastatin vs. No simvastatin was evaluated on Morphological changes of parotid gland. Simvastatin treatment in hyperlipidemic Wistar rats reduced chronic inflammation and lipocytes, promoting structural remodeling of the parotid gland.
Synapse has enriched 10 related papers. Consider them for comparative context: